Edition:
United Kingdom

Akebia Therapeutics Inc (AKBA.OQ)

AKBA.OQ on NASDAQ Stock Exchange Global Market

4.01USD
4:47pm BST
Change (% chg)

$0.23 (+6.08%)
Prev Close
$3.78
Open
$3.83
Day's High
$4.03
Day's Low
$3.81
Volume
60,665
Avg. Vol
383,355
52-wk High
$10.73
52-wk Low
$3.72

About

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of therapeutics based on hypoxia-inducible factor (HIF) biology. The Company's lead product candidate, vadadustat, is indicated for the treatment of anemia in chronic kidney disease (CKD). It is involved in... (more)

Overall

Beta: 1.02
Market Cap(Mil.): $894.46
Shares Outstanding(Mil.): 47.15
Dividend: --
Yield (%): --

Financials

  AKBA.OQ Industry Sector
P/E (TTM): -- 69.41 32.67
EPS (TTM): -3.62 -- --
ROI: -85.01 8.94 14.49
ROE: -147.39 10.07 15.79

Earnings vs. Estimates